🔎 Trials Near Me

Home › Multiple Sclerosis › Illinois › Chicago

Pag-aaral pangklinika para sa Multiple Sclerosis sa Chicago, IL

Isang pag-aaral para sa Multiple Sclerosis ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Nagre-recruitObservasyonal na pag-aaral
  • TG Therapeutics Investigational Trial Site, Chicago
  • TG Therapeutics Investigational Trial Site, Chicago
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06433752

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Nagre-recruitPhase 2
  • Rush University Medical Center, Chicago
  • University of Chicago Medical Center, Chicago
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07002034

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

Nagre-recruitPhase 3
  • University of Chicago Medical Center, Chicago
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06408259

Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain

Nagre-recruit
  • Shirley Ryan AbilityLab, Chicago
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07132775

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Nagre-recruitPhase 3
  • Northwestern Memorial Hospital, Chicago
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07225504

Ocrevus Zunovo for MS: Mixed Methods

Nagre-recruitObservasyonal na pag-aaral
  • Northwestern Memorial Hospital, Chicago
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT07710105

Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device

Nagre-recruit
  • University of Illinois at Chicago, Chicago
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT06410261

Functional Balance Intervention in Multiple Sclerosis

Nagre-recruit
  • University of Illinois at Chicago, Chicago
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT06341023

Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Nagre-recruit
  • University of Illinois at Chicago, Chicago
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT05051618

Nomad P-KAFO Study

Nagre-recruit
  • Shirley Ryan AbilityLab, Chicago
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update May 11, 2026 · NCT05644522

Intermittent Hypoxia in Persons With Multiple Sclerosis

Nagre-recruit
  • Shirley Ryan AbilityLab, Chicago
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT06276634

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Nagre-recruitObservasyonal na pag-aaral
  • Northwestern Memorial Hospital, Chicago
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT07207148

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

Nagre-recruitPhase 4
  • Northwestern Memorial Hospital, Chicago
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT07225361

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Nagre-recruit
  • Shirley Ryan AbilityLab, Chicago
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Peb 23, 2026 · NCT06390930

Home Based Functional Balance Intervention for Multiple Sclerosis

Nagre-recruit
  • University of Illinois at Chicago, Chicago
Edad 40 hanggang 90 · Lahat ng kasarian · Na-update Ene 21, 2026 · NCT07355387

Pag-aaral para sa Multiple Sclerosis sa ibang lungsod

Iba pang pag-aaral sa Chicago

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.